14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -7.594 16 days ( 58.42 % )
Last Price $2.42 -15.68 %
High/ Low $2.27 - $3.21 -37.00%
Chg 7 Days -40.83 % $4.09 $2.42
Chg 30 Days -60.52 % $6.13 $2.42
Chg 12 mos 1,437.48 % $0.157 $2.42
Trend - 3 mos -23.52 % Width: 90.74 %
Trend - 12 mos 77.33 % Width: 484.51 %
Pred. range - 3 mos $2.33 - $4.44 -3.78 % - 83.52 %
Pred. range - 12 mos $4.29 - $25.08 77.33 % - 936.48 %
Short MA avg 3 mos Buy Apr 11, 2024 - 18 days
Long MA avg 3 mos Sell Apr 15, 2024 - 16 days
Short/Long MA avg 3 mos Sell Apr 17, 2024 - 14 days
Short MA avg 12 mos Sell Apr 12, 2024 - 17 days
Long MA avg 12 mos Sell Jan 11, 2024 - 80 days
Short/Long MA avg 12 mos Sell Jan 19, 2024 - 75 days
Pivot Short Sell Apr 03, 2024 - 24 days
Bollinger Buy Apr 17, 2024 - 14 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Helius Medical Technologies, Inc.

Helius Medical Technologies. Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic... HSDT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT